As a scientist and CEO of a woman-led and -owned health and science agency, I am honored to count myself in the growing representation of women leaders in healthcare and biotech-related businesses. In 2021, women represented about 23% of biotech CEOs and about 15% of health system CEOs. And in 2023, for the first time in U.S. history, 10% of Fortune 500 CEOs were women.

While women in STEM may have finally broken the glass ceiling to achieve leadership roles, the reality is that now we are standing on a glass floor. It feels like simultaneously paving the way forward and being held back because many steps still include continued gender bias and unfair expectations, requiring extra effort not to slip.

Read more at: https://www.forbes.com/sites/forbesagencycouncil/2023/08/22/building-an-equitable-future-for-female-leaders-in-health-science-and-biotech/?sh=67d33e193456